Gemcitabine-induced large vessel vasculitis demonstrated by PET CT: a rare, important side effect

被引:8
作者
Eyre, Toby A. [1 ]
Gooding, Sarah [1 ]
Patel, Ishita [2 ]
Moore, Niall [3 ]
Hatton, Chris [1 ]
Collins, Graham P. [1 ]
机构
[1] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Haematol, Oxford OX3 7EJ, England
[2] Oxford Univ Hosp NHS Trust, Nuffield Orthopaed Ctr, Dept Rheumatol, Oxford OX3 7HE, England
[3] Oxford Univ Hosp NHS Trust, John Radcliffe Hosp, Dept Radiol, Oxford OX3 9DU, England
关键词
Aortitis; Gemcitabine; PET-CT; THERAPY; CARCINOMA;
D O I
10.1007/s12185-014-1555-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gemcitabine is a nucleoside analogue used widely across haemato-oncology. Side effects are generally predictable, and typically consist of cytopenia, nausea, and infection. As the present case clearly demonstrates, gemcitabine is in rare cases associated with life-threatening large vessel vasculitis, which can involve the aorta. It is important to consider gemcitabine-induced vasculitis in non-specifically unwell patients with raised inflammatory markers and fever of unknown origin, with or without signs of vascular compromise. Early recognition, cessation of gemcitabine therapy, and high-dose steroids are critical for a good outcome. PET CT is valuable to diagnose large vessel vasculitis and monitor treatment response.
引用
收藏
页码:798 / 800
页数:3
相关论文
共 11 条
[1]  
Banach MJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P726
[2]   Sonography and CT of vasculitis during gemcitabine therapy [J].
Bendix, N ;
Glodny, B ;
Bernathova, M ;
Bodner, G .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (03) :S14-S15
[3]   Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder [J].
Birlik, M ;
Akar, S ;
Tuzel, E ;
Onen, F ;
Ozer, E ;
Manisali, M ;
Kirkali, Z ;
Akkoc, N .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (02) :122-125
[4]   Cutaneous vasculitis associated with gemcitabine therapy [J].
Corella, F. ;
Dalmau, J. ;
Roe, E. ;
Garcia-Navarro, X. ;
Alomar, A. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (01) :97-99
[5]   Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal cancer [J].
Geisler, JP ;
Schraith, DF ;
Manahan, KJ ;
Sorosky, JI .
GYNECOLOGIC ONCOLOGY, 2004, 92 (02) :705-707
[6]   CUTANEOUS T-CELL LYMPHOMAS [J].
LAMBERG, SI ;
BUNN, PA .
ARCHIVES OF DERMATOLOGY, 1979, 115 (09) :1103-1105
[7]   Gemcitabine-Associated Large Vessel Vasculitis Presenting as Fever of Unknown Origin [J].
Ramsay, Laura B. ;
Stany, Michael P. ;
Edison, Jess D. ;
Bernstein, Sarah A. ;
Schlegal, Kevin E. ;
Hamilton, Chad A. .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (04) :181-182
[8]   Cerebral vasculitis associated with gemcitabine [J].
Schmorl, P. ;
Heer-Sonderhoff, A. ;
Vosshenrich, R. ;
Conrad, S. .
UROLOGE, 2010, 49 (02) :268-270
[9]   Chronic Thrombotic Microangiopathy Secondary to Chemotherapy for Urothelial Carcinoma in a Patient With a History of Wegener Granulomatosis [J].
Thomas, Jacob G. ;
Sethi, Sanjeev ;
Norby, Suzanne M. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (05) :799-802
[10]  
Venat-Bouvet L, 2003, Anticancer Drugs, V14, P829